Harvard Apparatus Regenerative Technology, Inc. (HRGN) stock
HRGNOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$2.21−0.02 (-0.72%)
Close on Oct 19, 2026Market cap $40.13MP/E –Yield –
Harvard Apparatus Regenerative Technology profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Harvard Apparatus Regenerative Technology's profit margin for the twelve months ending Sep 30, 2026 was -642.0%. For fiscal 2025 it was -975.7%, against -1798.1% the year before. The highest annual figure on record is -975.7% in fiscal 2025.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -975.7% | +822.4 |
| FY2024 | Dec 31, 2024 | -1798.1% | +6886.3 |
| FY2023 | Dec 31, 2023 | -8684.5% | +5436.3 |
| FY2016 | Dec 31, 2016 | -14120.7% | −4202.1 |
| FY2015 | Dec 31, 2015 | -9918.6% | +1974.9 |
| FY2014 | Dec 31, 2014 | -11893.5% | +28183.7 |
| FY2013 | Dec 31, 2013 | -40077.3% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -1009.0% | +373.1 |
| Q2 FY2026 | Jun 30, 2026 | -409.4% | +165.7 |
| Q1 FY2026 | Mar 31, 2026 | -708.4% | +2978.3 |
| Q4 FY2025 | Dec 31, 2025 | -770.3% | −249.4 |
| Q3 FY2025 | Sep 30, 2025 | -1382.1% | +1770.4 |
| Q2 FY2025 | Jun 30, 2025 | -575.1% | +3885.6 |
| Q1 FY2025 | Mar 31, 2025 | -3686.7% | −125.3 |
| Q4 FY2024 | Dec 31, 2024 | -520.9% | +2377.5 |
| Q3 FY2024 | Sep 30, 2024 | -3152.5% | +885.0 |
| Q2 FY2024 | Jun 30, 2024 | -4460.7% | +7475.0 |
| Q1 FY2024 | Mar 31, 2024 | -3561.4% | – |
| Q4 FY2023 | Dec 31, 2023 | -2898.4% | – |
| Q3 FY2023 | Sep 30, 2023 | -4037.5% | – |
| Q4 FY2016 | Dec 31, 2016 | -11935.7% | – |
See a number that looks wrong?